Artificial intelligence, biotechnology and advanced computing facilities are opening new channels for Thai companies seeking ...

Perth biotech Syngenis Labs has banked an oversubscribed $4M pre-IPO raise to expand its AI-powered RNA platform and ...

The funds will support the progression of MindRank’s pipeline, which is heavily dominated by obesity indications.

June 2026 saw drug development in oncology and neurology continue and biotech deals over small molecules and RNA therapies ...

Call AI in biotech hype at your peril. There are real reasons that pharmaceutical companies are embracing this technology ...

In South San Francisco, Genentech showed that recombinant DNA technology could transform medicine and create therapies once ...

VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, has begun cell line development ...

Greenland Mines Ltd (Nasdaq: GRML) ("Greenland Mines" or the "Company") today announced that IP Australia has granted Australian Patent ...

When we last sat down with Jobs at TechCrunch Disrupt nearly three years ago, his firm Yosemite was brand new and biotech was ...

As climate change brings longer droughts, more frequent heat waves and increasingly unpredictable growing conditions to ...

Looking at statistics from openrouter shows Grok 4.5 could capture a lot of AI spending market share by dominating the value ...

GSK has walked away from a $2.2 billion biobucks neurodegenerative disease pact with Alector that has seen both drugs ...